Development of acute dystonia in three brothers due to metoclopramide
One of the agents that cause dystonic reactions is metoclopramide. In this study, we presented three individuals of the same family who were admitted to our hospital while receiving the treatment of metoclopramide because of developing acute dystonic ...
Ibrahim Silfeler +3 more
doaj +4 more sources
Metoclopramide-induced central nervous system depression in the chicken [PDF]
Background Metoclopramide is a dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in man and animals. The drug causes sedation as a side effect in man.
Mohammad Fouad K, Al-Zubaidy Muna HI
doaj +2 more sources
Metoclopramide-induced cardiac arrest
The authors report a case of cardiac arrest in a patient receiving intravenous (IV) metoclopramide and review the pertinent literature. A 62-year-old morbidly obese female admitted for a gastric sleeve procedure, developed cardiac arrest within one ...
Martha M. Rumore +3 more
doaj +2 more sources
The effect of a physician-targeted intervention on metoclopramide prescribing practice
Yu-Xiao Yang1,2,3, Charles E Leonard2,3, Cristin Freeman2,3, Sean Hennessy2,31Division of Gastroenterology, 2Center for Clinical Epidemiology and Biostatistics, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA ...
Yang YX +3 more
doaj +1 more source
Polymorphism in metoclopramide hydrochloride and metoclopramide
Abstract Metoclopramide hydrochloride (MCPHCl.H2O) and metoclopramide base (MCP) have been studied by DSC, thermomicroscopy, X-ray diffraction and infrared spectroscopy. MCPHCl.H2O does not readily lose water of crystallization either from the solid state or from the melt, but depending on the conditions, dehydration can give rise to two
A G Mitchell
openaire +3 more sources
Metoclopramide-induced acute dystonic reaction: A case report
Metoclopramide, a common antiemetic, is associated with extrapyramidal side effects. This case report describes a 19-year-old male with dengue fever who developed involuntary muscle contractions and respiratory distress two hours after receiving ...
Shafiq Ur Rahman +2 more
doaj +2 more sources
Economic evaluation of ondansetron: Preliminary analysis using clinical trial data prior to price setting [PDF]
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright © 1992 Macmillan Press Ltd.This study combines secondary analysis of efficacy and side-effect data from a randomised ...
Buxton, MJ, O'Brien, BJ
core +6 more sources
Receptor-Targeted Antiemetic Strategies in Cats: A Systematic Review and Intervention-Specific Meta-Analysis. [PDF]
Maropitant showed the most consistent controlled evidence for reducing emesis incidence in cats under perioperative or induced‐emesis conditions. Ondansetron may be beneficial in timing‐specific settings, whereas metoclopramide evidence remains insufficient for pooled inference. .
Ersöz U, Özkalipci Ç.
europepmc +2 more sources
Persistent Post-Traumatic Brain Injury Hiccups Unresponsive to Standard Agents: Resolution Associated With Levetiracetam Therapy. [PDF]
ABSTRACT Post‐traumatic hiccups are an uncommon but distressing complication of traumatic brain injury (TBI), often resistant to conventional pharmacological agents, and the underlying mechanism may involve central neurological disruption of inhibitory pathways rather than gastrointestinal or metabolic aetiologies. We report a male patient in his early
Karajeh R +4 more
europepmc +2 more sources
Tardive Dyskinesia in Patients Receiving Continuous Versus Intermittent Oral Metoclopramide: A Retrospective Real World Study. [PDF]
Continuous MCP dosing was associated with higher TD prevalence and earlier onset. Intermittent dosing, despite longer cumulative exposure, was associated with lower TD risk. These findings suggest that intermittent regimens may offer a safer MCP therapeutic strategy. ABSTRACT Background Tardive dyskinesia (TD) is an often irreversible movement disorder
Russo P, Nathan R, Camilleri M.
europepmc +2 more sources

